Bcr-Abl inhibitor Vodobatinib, Purity ≥98%

Synonym: 1388803-90-4; Vodobatinib, Purity ≥98%; Vodobatinib; K-0706; K0706; K0706

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Vodobatinib It targets .

Molecular Weight

453.926

Molecular Formula

C₂₇H₂₀ClN₃O₂

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

Vodobatinib is researched as a novel kinase inhibitor for its effects on Bcr-Abl and other kinases in treating leukemia.